1. Adler, V., Unlap, T. & Kraft, A. S. (1994). A peptide encoding the c-Jun δ domain inhibits the activity of a c-Jun amino-terminal protein kinase. J Biol Chem 269: 11186–11191.
2. Ahnen, D. J., Feigl, P., Quan, G., Fenoglio-Preiser, C., Lovato, L. C., Bunn, P. A., Stemmerman, G., Wells, J. D., MacDonald, J. S. & Meyskens, F. L. (1998). Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a southwest oncology group study. Cancer Res 58: 1149–1158.
3. Allgayer, H., Heiss, M. M., Riesenberg, R., Grutzner, K. U., Tarabichi, A., Babic, R. & Schildberg, F. W. (1997). Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 57: 1394–1399.
4. Allgayer, H., Wang, H., Wang, Y., Heiss, M. M., Bauer, R., Nyormoi, O. & Boyd, D. (1999). Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor. J Biol Chem 274: 4702–4714.
5. Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F. & Dano, K. (1991). The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266: 7842–7847.